Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Participants who attended the climacteric consultation for the first time, without prior treatment of menopausal symptoms, and who met postmenopausal criteria.~* Participants who met the criteria for vasomotor syndrome and score greater than 17 points in total MRS.~* Participants without psychiatric pathology (psychiatric illnesses such as major depression, generalized anxiety disorder, among others).~* Participants who agreed to participate and gave their written informed consent.~Exclusion Criteria:~* Participants who had contraindications to receive serotonin reuptake inhibitors (SSRIs).~* Participants who were receiving prior treatment for the postmenopausal or vasomotor syndrome.~* Participants who did not agree to participate or sign the informed consent.

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fluoxetine group (Type: ACTIVE_COMPARATOR): Participants received fluoxetine, 20 mg tablets, once a day for six months.
- Citalopram group (Type: EXPERIMENTAL): Participants received citalopram, 20 mg tablets, once a day for six months.

Based on this trial design, predict the completion outcome and termination type (if applicable).